What is AZN's current stock price?

As of now, AZN is trading at $83.40, with a daily change of -0.04%.

What are the risks associated with AZN stock?

AZN Key risk is its Low Risk Level, .

What is AZN next earnings date?

AZN next earnings report is scheduled for Nov 6, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AZN Stock Analysis & IQ Rating | Astrazeneca

AZN

Astrazeneca

$83.40

-$0.03 | -0.04%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 86.57

MKT CAP

$ 259.10B

52W Low

$ 61.24

VOL

$ 2.14M

P/E Ratio

31.4

AVG VOL

$ 5.61M

RSI

55.19

TREND

Uptrend

AZN Stock IQ

Login to see Astrazeneca (AZN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AZN Target Price

Login to display

Strengths

AZN Rewards

Earnings are forecast to grow

AZN Rewards

Upgraded on attractively valued

AZN Rewards

Trading below its fair value

Chart

$73.76 (+13.07%)

$75.2 (+10.90%)

$71.82 (+16.12%)

$63.85 (+30.62%)

1year

6month

3month

1month

AZN Risk Level

AZN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

AZN Analysts Opinion

AZN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AZN Analysts Opinion

AZN Analysts opinion is positive and also has improved from the past 3 months

AZN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

90%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

100%

67%

AZN Street Opinion

AZN Street view is extremely bullish and have positive views on the near-term outlook

AZN Performance Sentiment

Sentiments overview associated with AZN events and the stock performance.

90%

8%

Positive

Negative

35 out of 39
events present

3 out of 39
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$83.25

Resistance
Price

$73.53

Current Price Range

$85.93

Show methods +

AZN Earnings

The TTM reflects 12-month period, providing review of AZN financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

56,501

54,073

45,811

+11.06%

Cost of Revenue

10,520

10,207

8,268

+12.80%

Gross Profit

45,981

43,866

37,543

+10.67%

Operating Exp

34,409

33,615

28,821

+9.27%

Operating Inc

11,572

10,251

8,722

+15.19%

Net Interest Inc

-1,328

-1,337

-1,288

-

Interest Exp

1,611

1,682

1,589

+0.69%

Interest Inc

283

345

301

-3.04%

EPS Growth

2.67

2.27

1.92

+17.92%

AZN Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.74

Next Earnings Date: Nov 6, 2025

Linked to AZN

IQ

Close Price

Change

NVS

4.26

131.64

+0.15%

PFE

4.09

24.67

-0.22%

MRK

4.05

87.18

-0.55%

SNY

3.84

49.52

-0.94%

TEVA

4.37

19.02

+0.37%

AZN Latest Analysis +

Berenberg Bank Reiterates AstraZeneca PLC - Depositary Receipt (AZN) Buy Recommendation. Fintel reports that on October 21 2025 Berenberg Bank reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Buy recommendation. Analyst Price Forecast Suggests 8.37% Upside

Thu Oct 23, 2025

$83.40 | -0.04%

Rating

Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug AstraZeneca Partnership.

Thu Oct 23, 2025

$83.40 | -0.04%

Activity

J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN) Sets a £140 PT. AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to buy right now. AstraZeneca PLC (NASDAQ:AZN) received a rating update from J.P. Morgan analyst Richard Vosser on October 20 who assigned the stock a Buy rating with a £140 price target. The rating update followed AstraZeneca PLCs (NASDAQ:AZN) announcement of positive results [….]

Thu Oct 23, 2025

$83.40 | -0.04%

Activity

Potential

Rating

AstraZeneca PLC (AZN) Presents at ESMO Congress 2025 - Slideshow.

Tue Oct 21, 2025

$83.22 | -0.78%

Activity

Heres Why Astrazeneca (AZN) is a Strong Momentum Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Mon Oct 20, 2025

$83.87 | -0.97%

Momentum

AstraZenecas Imfinzi Improves Disease-Free Survival In Early-Stage Bladder Cancer . (RTTNews) - AstraZeneca (AZN) Friday announced positive Phase III results from its POTOMAC trial showing that adding one year of treatment with Imfinzi. durvalumab to standard BCG therapy significantly improved disease-free survival in patients with BCG-naï.ve high-risk non-mus

Fri Oct 17, 2025

$84.69 | +1.03%

Activity

Potential

AstraZeneca reports positive data from Imfinzis bladder cancer trial.

Fri Oct 17, 2025

$84.69 | +1.03%

Activity

2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades. Key PointsEli Lilly and AstraZeneca are two of the most promising stocks in healthcare.

Thu Oct 16, 2025

$83.83 | -1.18%

Potential

Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Tue Oct 14, 2025

$85.12 | +0.72%

Potential

JP Morgan Cazenove Reiterates AstraZeneca PLC - Depositary Receipt (AZN) Overweight Recommendation. Fintel reports that on October 13 2025 JP Morgan Cazenove reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Overweight recommendation. Analyst Price Forecast Suggests 6.99% Upside

Tue Oct 14, 2025

$85.12 | +0.72%

Rating

FAQ About AZN Stock Insights

What is AZN current stock price?

What are AZN stock strengths?

What risks are associated with AZN stock?

When is AZN next earnings report?

What is AZN market cap and volume?

What is AZN's current Stock IQ?

Should I buy AZN stock right now?

Is AZN a Strong Buy right now?

What does a 'Strong Buy' rating mean for AZN?

What does a 'Strong Sell' rating mean for AZN?

What factors influence AZN's Stock IQ?

Explore our AZN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AZN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AZN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AZN

Astrazeneca

Current Price

$83.40

-$0.03 | -0.04%

52W High

$ 86.57

MKT CAP

$ 259.10B

52W Low

$ 61.24

VOL

$ 2.14M

P/E Ratio

31.4

AVG VOL

$ 5.61M

RSI

55.19

TREND

Uptrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

AZN Rewards

Earnings are forecast to grow

AZN Rewards

Upgraded on attractively valued

AZN Rewards

Trading below its fair value

Linked to AZN

Symbol

IQ

Close

Change

NVS

4.26

131.64

+0.15%

PFE

4.09

24.67

-0.22%

MRK

4.05

87.18

-0.55%

SNY

3.84

49.52

-0.94%

TEVA

4.37

19.02

+0.37%

AZN Stock IQ

Login to unlock Astrazeneca (AZN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$73.76 (+13.07%)

$75.2 (+10.90%)

$71.82 (+16.12%)

$63.85 (+30.62%)

1year

6month

3month

1month

AZN Analysts Opinion

AZN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

AZN Analysts Opinion

AZN Analysts opinion is positive and also has improved from the past 3 months

AZN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

90%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

100%

67%

AZN Street Opinion

AZN Street view is extremely bullish and have positive views on the near-term outlook

AZN Risk Level

AZN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

AZN Performance Sentiment

Sentiments overview associated with AZN events and the stock performance.

90%

8%

Positive

Negative

35 out of 39
events present

3 out of 39
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$83.25

Resistance
Price

$73.53

Current Price Range

$85.93

Show methods +

AZN Earnings

The TTM data reflects the most recent 12-month period, providing overview of AZN financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

56,501

54,073

45,811

+11.06%

Cost of Revenue

10,520

10,207

8,268

+12.80%

Gross Profit

45,981

43,866

37,543

+10.67%

Operating Exp

34,409

33,615

28,821

+9.27%

Operating Inc

11,572

10,251

8,722

+15.19%

Net Interest Inc

-1,328

-1,337

-1,288

-

Interest Exp

1,611

1,682

1,589

+0.69%

Interest Inc

283

345

301

-3.04%

EPS Growth

2.67

2.27

1.92

+17.92%

AZN Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.74

Next Earnings Date: Nov 6, 2025

AZN Latest Analysis

Berenberg Bank Reiterates AstraZeneca PLC - Depositary Receipt (AZN) Buy Recommendation. Fintel reports that on October 21 2025 Berenberg Bank reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Buy recommendation. Analyst Price Forecast Suggests 8.37% Upside

Thu Oct 23, 2025

$83.40 | -0.04%

Rating

Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug AstraZeneca Partnership.

Thu Oct 23, 2025

$83.40 | -0.04%

Activity

J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN) Sets a £140 PT. AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to buy right now. AstraZeneca PLC (NASDAQ:AZN) received a rating update from J.P. Morgan analyst Richard Vosser on October 20 who assigned the stock a Buy rating with a £140 price target. The rating update followed AstraZeneca PLCs (NASDAQ:AZN) announcement of positive results [….]

Thu Oct 23, 2025

$83.40 | -0.04%

Activity

Potential

Rating

AstraZeneca PLC (AZN) Presents at ESMO Congress 2025 - Slideshow.

Tue Oct 21, 2025

$83.22 | -0.78%

Activity

Heres Why Astrazeneca (AZN) is a Strong Momentum Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Mon Oct 20, 2025

$83.87 | -0.97%

Momentum

AstraZenecas Imfinzi Improves Disease-Free Survival In Early-Stage Bladder Cancer . (RTTNews) - AstraZeneca (AZN) Friday announced positive Phase III results from its POTOMAC trial showing that adding one year of treatment with Imfinzi. durvalumab to standard BCG therapy significantly improved disease-free survival in patients with BCG-naï.ve high-risk non-mus

Fri Oct 17, 2025

$84.69 | +1.03%

Activity

Potential

AstraZeneca reports positive data from Imfinzis bladder cancer trial.

Fri Oct 17, 2025

$84.69 | +1.03%

Activity

2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades. Key PointsEli Lilly and AstraZeneca are two of the most promising stocks in healthcare.

Thu Oct 16, 2025

$83.83 | -1.18%

Potential

Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Tue Oct 14, 2025

$85.12 | +0.72%

Potential

JP Morgan Cazenove Reiterates AstraZeneca PLC - Depositary Receipt (AZN) Overweight Recommendation. Fintel reports that on October 13 2025 JP Morgan Cazenove reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Overweight recommendation. Analyst Price Forecast Suggests 6.99% Upside

Tue Oct 14, 2025

$85.12 | +0.72%

Rating

Discover AZN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AZN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AZN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AZN Stock trends

AZN Stock performance

AZN Stock analysis

AZN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AZN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AZN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AZN Stock Analysis & IQ Rating | Astrazeneca

AZN Stock IQ

AZN Target Price

AZN Risk Level

AZN Analysts Opinion

AZN Street Consensus

AZN Performance Sentiment

Technical Price Levels

AZN Financial Health

Explore our AZN Stock insights

Receive our AZN Daily Alerts

AZN Stock IQ

AZN Street Consensus

AZN Risk Level

Technical Price Levels

Discover AZN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AZN. We're here to help you make informed investment decisions today.

Receive our AZN Daily Alerts

AZN Runner Alarm